scarletred
Home
Company
Products
Scarletred
®Vision
Scarletred
®Telemedicine
Services
Applications
CAREER
News
Contact
Menu
01
Home
02
Company
03
Products
04
Services
05
Applications
06
News
07
Contact
Get in touch
Austria
SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1,
8th floor, 1030 Vienna, Austria
USA
SCARLETRED Inc.
1 Broadway, 14th floor,
Cambridge, MA 02142, USA
office@scarletred.com
Privacy Policy
Social
Linkedin
Linkedin
Linkedin
Twitter
Instagram
Instagram
Facebook
Facebook
info
Press
Career
FAQ
Regulatory
Imprint
COVID19
Keywords:
#
AAD 2024
#
Tissue Classifier
#
Conferences
#
Skin Care
#
AAD 2023
#
BioJapan2022
#
JAK inhibitors
News
•
Mar 7, 2022
New Diagnostic Accuracy Study Assessing SARS-CoV-2 Rapid Antigen Detection Tests using Scarletred®Vision
A study, performed by the Medical University of Vienna, examined diagnostic accuracy of SARS-CoV-2 rapid antigen tests compared to RT-PCR as the gold standard based on different swab sites by using Scarletred®Vision.
Article
•
Aug 3, 2020
Virtualization - The Golden Age of Home-Based Trials has Started
Due to the COVID-19 pandemic, researchers need to adjust clinical trial setups due to the stay-at-home orders and risk of virus transmission. The golden time of virtual and home-based clinical trials has started.
Article
•
Jul 28, 2020
Digital Momentum in Preclinical Drug Screening and Safety Assessment
The current COVID-19 pandemics forced many clinical trials to grind to a halt, stalling research until restrictions are lifted. Scarletred offers a solution for the documentation and monitoring of changes on the skin surface.
Paper
•
November 30, 2023
Automated Classification of Hidradenitis Suppurativa Disease Severity by Convolutional Neural Network Analyses Using Calibrated Clinical Images
Read more